Bicycle Therapeutics plc ( BCYC) - Key Metrics
BCYC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.72 | -$0.71 | -$0.71 |
| 2026Q1 | $0.01 | -$0.87 | -$0.95 | -$0.96 |
| 2025Q4 | $0.69 | -$0.29 | -$0.27 | -$0.25 |
| 2025Q3 | $0.17 | -$0.85 | -$1.03 | -$1.04 |
| 2025Q2 | $0.04 | -$1.14 | -$1.05 | -$1.06 |
BCYC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.47 |
| 2026Q1 | 0% | -1.33 |
| 2025Q4 | 0% | -6.10 |
| 2025Q3 | 0% | -2.28 |
| 2025Q2 | 0% | -1.52 |
BCYC
Price: $3.90
52 week price:
Earnings Per Share: -2.73 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 365200
Market Capitalization: 277.9 million